Core Scientific (CORZ) reported a Q4 net loss late Wednesday of $0.60 per diluted share, widening from a loss of $0.51 a year earlier.
Analysts polled by FactSet expected a loss of $0.09.
Revenue for the quarter ended Dec. 31 was $94.9 million, down from $141.9 million a year earlier. Analysts surveyed by FactSet expected $98.8 million.
Shares of the company were up over 10% in after-hours activity.